Masterclass in Immunooncology

Προεδρείο: Κ. Μπαξεβάνης  09.00-09.30 Historical retrospection in the research     of the genetic basis  of cancer Β. Ζουμπουρλής  09.30-10.00 Epigenetic modifications in cancer.     Diagnostic and therapeutic approaches Α. Γιακουντής  10.00-10.30 Cancer Immunology Π. Μπατσάκη  10.30-10.45 General Discussion (all presenters) 

11.15-11.45 TME and Immunotherapeutics  Ε. Κούστας  11.45-12.15 Interactions between tumor associated     macrophages (TAMs) and cancer Ι. Πατέρας  12.15-12.45 B cells as an essential part for humoral     antitumor immunity in the TME Σ. Καραγιάννη   12.45-13.15 Hypoxia and angiogenesis in tumor     microenvironment Π. Λιάκος  13.15-13.30 General Discussion (all presenters)

Προεδρείο: Ι. Πατέρας 13.45-14.15 Cancer immune biomarkers in the era of precision     oncology Γ. Τσαούσης  14.15-14.45 Oncolytic virus therapy in cancer  Α. Λασκαράκης  14.45-15.15 Immunotherapeutic approaches in Head     and Neck Π. Κατσαούνης  15.15-15.45 Immunotherapeutic advances in     Breast Cancer Ι. Δημητριάδης  15.45-16.15 The evolving landscape of immunotherapy     in NSCLC Θ. Τέγος   16.15-16.30 General Discussion (all presenters)

Προεδρείο: Μ. Γουλιελμάκη  17.00-17.30 Peptide-based vaccines K. Μπαξεβάνης   17.30-18.00 Mechanisms of action of Immune     Checkpoint Inhibitor Ε. Αναστασoπούλου  18.00-18.30 Immuno-oncology pathways and treatment Π. Σαράντης  18.30-19.00 Autoimmunity and immunotherapy Δ. Μπόγδανος  19.00-19.15 General Discussion (all presenters)

Προεδρείο: Σ. Φόρτης  19.15-19.45 Mechanisms for immune resistance     during immunotherapies Π. Βεργίνης  19.45-20.15 Systemic immune activation during     radiotherapy M. Κουκουράκης  20.15-20.30 General Discussion (all presenters)